Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Terkeltaub

Showing results (1-10 of 159) with videos related to

Pageof 16
Sort By:
BMC Medicine|August 19, 2017
What makes gouty inflammation so variable?Robert Terkeltaub
Bulletin of the NYU Hospital for Joint Diseases|November 24, 2006
Gout in 2006: the perfect stormRobert Terkeltaub
Arthritis Research & Therapy|December 29, 2012
Imaging joints for calcium pyrophosphate crystal deposition: a knock to the kneesRobert Terkeltaub
Drugs|October 11, 2023
Emerging Urate-Lowering Drugs and Pharmacologic Treatment Strategies for Gout: A Narrative ReviewRobert Terkeltaub
Arthritis Research & Therapy|August 12, 2009
Gout. Novel therapies for treatment of gout and hyperuricemiaRobert Terkeltaub
Purinergic Signalling|April 12, 2008
Physiologic and pathologic functions of the NPP nucleotide pyrophosphatase/phosphodiesterase family focusing on NPP1 in calcificationRobert Terkeltaub
Nature Reviews. Rheumatology|January 5, 2010
Update on gout: new therapeutic strategies and optionsRobert Terkeltaub
Arthritis & Rheumatology (Hoboken, N.J.)|January 20, 2025
The Gut Microbiome in Hyperuricemia and GoutRobert Terkeltaub, Dylan Dodd
Current Rheumatology Reports|March 20, 2009
A critical reappraisal of allopurinol dosing, safety, and efficacy for hyperuricemia in goutJeannie Chao, Robert Terkeltaub
Current Rheumatology Reports|May 15, 2003
Calcium pyrophosphate dihydrate and hydroxyapatite crystal deposition in the joint: new developments relevant to the clinicianSalih Pay, Robert Terkeltaub
Pageof 16

Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
BMC Medicine|August 19, 2017
What makes gouty inflammation so variable?Robert Terkeltaub
Bulletin of the NYU Hospital for Joint Diseases|November 24, 2006
Gout in 2006: the perfect stormRobert Terkeltaub
Arthritis Research & Therapy|December 29, 2012
Imaging joints for calcium pyrophosphate crystal deposition: a knock to the kneesRobert Terkeltaub
Drugs|October 11, 2023
Emerging Urate-Lowering Drugs and Pharmacologic Treatment Strategies for Gout: A Narrative ReviewRobert Terkeltaub
Arthritis Research & Therapy|August 12, 2009
Gout. Novel therapies for treatment of gout and hyperuricemiaRobert Terkeltaub
Purinergic Signalling|April 12, 2008
Physiologic and pathologic functions of the NPP nucleotide pyrophosphatase/phosphodiesterase family focusing on NPP1 in calcificationRobert Terkeltaub
Nature Reviews. Rheumatology|January 5, 2010
Update on gout: new therapeutic strategies and optionsRobert Terkeltaub
Arthritis & Rheumatology (Hoboken, N.J.)|January 20, 2025
The Gut Microbiome in Hyperuricemia and GoutRobert Terkeltaub, Dylan Dodd
Current Rheumatology Reports|March 20, 2009
A critical reappraisal of allopurinol dosing, safety, and efficacy for hyperuricemia in goutJeannie Chao, Robert Terkeltaub
Current Rheumatology Reports|May 15, 2003
Calcium pyrophosphate dihydrate and hydroxyapatite crystal deposition in the joint: new developments relevant to the clinicianSalih Pay, Robert Terkeltaub
Pageof 16